Fluticasone, umeclidinium, and vilanterol
Generic name: Fluticasone, Umeclidinium, And Vilanterol
Brand names: Trelegy Ellipta
Dosage form: inhalation powder (100 mcg-62.5 mcg-25 mcg/inh; 200 mcg-62.5 mcg-25 mcg/inh)
Drug class:
Bronchodilator combinations
Usage of Fluticasone, umeclidinium, and vilanterol
Fluticasone, umeclidinium, and vilanterol is a combination medicine used to prevent airflow obstruction and reduce flare-ups in adults with COPD (chronic obstructive pulmonary disease), including bronchitis and emphysema.
Fluticasone, umeclidinium, and vilanterol is also used to prevent and control symptoms of asthma in adults.
fluticasone, umeclidinium, and vilanterol is not for use in treating an asthma or bronchospasm attack.
Vilanterol when used alone may increase the risk of death in people with asthma. However, this risk is not increased when vilanterol is used in a combination product with fluticasone and umeclidinium.
Fluticasone, umeclidinium, and vilanterol may also be used for purposes not listed in this medication guide.
Fluticasone, umeclidinium, and vilanterol side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Fluticasone, umeclidinium, and vilanterol may cause serious side effects. Call your doctor at once if you have:
Common side effects of fluticasone, umeclidinium, and vilanterol may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Fluticasone, umeclidinium, and vilanterol
You should not use this medicine if you are allergic to fluticasone, umeclidinium, vilanterol, or milk proteins.
Tell your doctor if you have ever had:
If you have been using an oral steroid medication, you should not stop using it suddenly. Follow your doctor's instructions about tapering your dose.
Tell your doctor if you are pregnant or breastfeeding.
This medicine is not approved for use by anyone younger than 18 years old.
Relate drugs
- Aclidinium and formoterol
- Advair
- Advair Diskus
- Advair Diskus 100/50
- Advair Diskus 250/50
- Advair Diskus 500/50
- Advair HFA
- Advair HFA 115/21
- Advair HFA 230/21
- Advair HFA 45/21
- AirDuo Digihaler with eModule
- AirDuo RespiClick
- Albuterol and ipratropium inhalation
- Anoro Ellipta
- Combivent
- Combivent Respimat
- Combivent Respimat inhalation
- Bevespi Aerosphere
- Breo Ellipta
- Breztri Aerosphere
- Budesonide and formoterol
- Budesonide and formoterol inhalation
- Budesonide, formoterol, and glycopyrrolate
- Budesonide, glycopyrrolate, and formoterol
- Duaklir Pressair
- Dulera
- DuoNeb
- Fluticasone and salmeterol
- Fluticasone and vilanterol
- Fluticasone, umeclidinium, and vilanterol
- Formoterol and glycopyrrolate
- Formoterol and mometasone
- Glycopyrrolate and formoterol
- Indacaterol and glycopyrrolate
- Ipratropium and albuterol
- Mometasone and formoterol
- Olodaterol and tiotropium
- Stiolto Respimat
- Stiolto Respimat 10 ACT
- Stiolto Respimat 28 ACT
- Stiolto Respimat 60 ACT
- Symbicort
- Symbicort Aerosphere
- Tiotropium and olodaterol
- Trelegy Ellipta
- Umeclidinium and vilanterol
- Utibron Neohaler
How to use Fluticasone, umeclidinium, and vilanterol
Usual Adult Dose for Chronic Obstructive Pulmonary Disease -- Maintenance:
1 inhalation (fluticasone/umeclidinium/vilanterol 100 mcg-62.5 mcg-25 mcg) orally once a dayMaximum dose: 1 inhalation every 24 hoursComments:-More frequent administration or a greater number of inhalations than the recommended dose should not be used, as adverse effects are more likely to occur with higher doses.-Use with caution when transferring from systemically active corticosteroid therapy.-Patients requiring oral corticosteroids should be weaned slowly from systemic corticosteroid use after transferring to this drug.Uses: -Long-term maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema-Reduce exacerbations of COPD in patients with a history of exacerbations.
Usual Adult Dose for Asthma -- Maintenance:
1 inhalation (fluticasone/umeclidinium/vilanterol 100 mcg-62.5 mcg-25 mcg or 200 mcg-62.5 mcg-25 mcg) orally once a dayMaximum dose: 1 inhalation (fluticasone/umeclidinium/vilanterol 200 mcg-62.5 mcg-25 mcg) every 24 hoursComments:-When choosing starting dose, consider disease severity, previous asthma therapy (including inhaled corticosteroid use), current symptom control and risk of future exacerbations.-Patients with inadequate response to fluticasone/umeclidinium/vilanterol 100 mcg-62.5 mcg-25 mcg may gain additional improvement with fluticasone/umeclidinium/vilanterol 200 mcg-62.5 mcg-25 mcg.-Consider reevaluation and other therapies if response to fluticasone/umeclidinium/vilanterol 200 mcg-62.5 mcg-25 mcg is inadequate.-If asthma symptoms arise between doses, use and inhaled short-acting beta-2 agonist (e.g. albuterol) for immediate relief.
Warnings
Fluticasone, umeclidinium, and vilanterol is not a rescue medicine for asthma or bronchospasm attacks. Use only fast-acting inhalation medicine for an attack. Seek medical attention if your breathing problems get worse quickly, or if you think your medications are not working as well.
What other drugs will affect Fluticasone, umeclidinium, and vilanterol
Tell your doctor about all your other medicines, especially:
This list is not complete. Other drugs may affect fluticasone, umeclidinium, and vilanterol, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions